CDK1 and ovarian carcinoma: Studies from Choi et al. demonstrated that DE induces G2/M phase arrest in human ovarian cancer SK-OV-3 cells through up-regulation of p21, down-regulation of Cdk1 as well as cyclin A and cyclin B, which combine with Cdk1 in controlling the G2/M transition [9].